BioStorage Technologies, a worldwide provider of long- and short-term storage of biomaterials, sample management and cold chain logistics, today announced its full-service biorepository near Frankfurt, Germany received green certification from ENTEGA Vertrieb GmbH & Co., a leading Germany-based sustainable energy supplier.
Serving global pharmaceutical and biotech firms, donor organizations and biobanks as well as research and academic organizations, BioStorage Technologies’ 18,000 square-foot (1,672 square-meter) biorepository, uses an estimated 360,000-kilowatt hours (kWh) of power per year. By using 100 percent renewable energy, BioStorage Technologies is preventing the generation of an estimated 189 tons of environmentally harmful carbon dioxide (CO2) in the first year, thus making a valuable contribution to environmental protection. As the European operation grows, the amount of carbon dioxide prevented from generation will increase significantly.
“We are pleased to have all of our global facilities operating with 100 percent renewable energy,” said F. John Mills, M.D., Ph.D., chairman and chief executive officer at BioStorage Technologies. “This initiative demonstrates our commitment to conserving energy and improving the health of the environment by decreasing carbon dioxide emissions.”
Dr. Wolfgang Höffer, managing director of BioStorage Technologies’ European operations, adds, “Using renewable energy is only one of the green initiatives underway at our facilities. Additional aspects of the initiative include environmentally conscious management of waste disposal, logistics, water consumption and paper use.” BioStorage Technologies is also researching low VOC (Volatile Organic Compound) cleaning agents, the use of fair-trade products where applicable and other ways of making facilities and services better for the overall health of individuals and the environment.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.